Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2467${count})

  • Access to Data and Biospecimens, 2015
    BioFIND: Analysis of A-beta, Tau and P-tau in CSF Samples

    Study Rationale: Mixed pathology is common in all neurodegenerative diseases including Parkinson’s disease (PD).  Three cerebrospinal fluid (CSF) biomarkers, Ab1-42, t-tau and p-tau181, provide an...

  • Therapeutic Pipeline Program, 2015
    Effects of Transcranial Stimulation on Freezing of Gait in Parkinson's Disease

    Study Rationale:
    Many people with Parkinson's disease experience freezing of gait, when the person is unable to move forward, despite his or her best efforts. Although it is not exactly clear why or...

  • Access to Data & Biospecimens, 2015
    Evaluation of Alpha-synuclein and Hemoglobin Levels in CSF, Plasma and Saliva samples from the BioFind Cohort

    Study Rationale:                   

    Alpha-synuclein pathology plays a major role in Parkinson’s disease (PD). Recent studies suggest that measurement of alpha-synuclein in biological fluids (e.g...

  • Access to Data & Biospecimens, 2015
    NeuroX profiling of samples from the PPMI prodromal and genetic cohorts, the LRRK2 cohort consortium and the BioFIND cohort

    Study Rationale:                   

    This work aims to provide genetic information at common genetic variants and rare genetic variants that have been associated with Parkinson disease. To do this...

  • Access to Data & Biospecimens, 2015
    Whole Genome Sequencing and Analysis of the PPMI Prodromal and Genetic Cohorts, PPMI Genetic Registry and the LRRK2 Cohort Consortium

    Study Rationale:                   

    This work aims to provide genetic information for the whole genome and assess the role of the identified genetic information in Parkinson disease. To do this...

  • Therapeutic Pipeline Program, 2014
    Prevention of Levodopa-induced Dyskinesia by Transcranial Static Magnetic Field Stimulation

    Study Rationale:
    A major challenge in Parkinson’s treatment is the management of levodopa-induced dyskinesias. A promising approach is offered by non-invasive neuromodulation techniques. We recently...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.